09-12-2017 16:00 via prnewswire.com

Bioengineering and Specialized Therapies Yield Results for Rare and Challenging Blood Diseases

ATLANTA, Dec. 9, 2017 /PRNewswire-USNewswire/ -- In four studies being presented today during the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta, researchers announce promising findings on innovative tools and therapies for hard-to-treat blood disorders...
Read more »